| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/25/1994 | CA1326445C Cosmetic or pharmaceutical composition consisting of an aqueous dispersion of lipidic spherules |
| 01/25/1994 | CA1326438C Sustained and controlled release of water insoluble polypeptides |
| 01/23/1994 | CA2101117A1 Methods for detecting alzheimer's disease |
| 01/20/1994 | WO1994028021A1 Endometrial proteins, antigenic compositions and methods for detecting endometriosis |
| 01/20/1994 | WO1994001576A1 Novel flk-2 and analogs |
| 01/20/1994 | WO1994001570A1 K. lactis rp28 ribosomal protein gene promoter and use thereof |
| 01/20/1994 | WO1994001569A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 01/20/1994 | WO1994001566A1 A chimeric protein that has a human rho motif and deoxyribonuclease activity |
| 01/20/1994 | WO1994001558A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | WO1994001557A1 Bone formation-inducing protein |
| 01/20/1994 | WO1994001556A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | WO1994001555A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | WO1994001553A1 Receptor derivates with binding sites for human rhinoviruses |
| 01/20/1994 | WO1994001550A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | WO1994001549A1 Looped, hairpin ribozyme |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001536A1 Cancer immunotherapy with antibodies to cancer procoagulant |
| 01/20/1994 | WO1994001483A1 Biocompatible polymer conjugates |
| 01/20/1994 | WO1994001467A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | WO1994001466A1 Plasma fraction purification |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001463A1 USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS |
| 01/20/1994 | WO1994001462A1 Biologically active polypeptides derived from an actinomycete |
| 01/20/1994 | WO1994001461A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 01/20/1994 | WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 01/20/1994 | WO1994001459A1 A fungicidally active compound |
| 01/20/1994 | WO1994001457A1 Interferon receptor binding peptides |
| 01/20/1994 | WO1994001456A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention |
| 01/20/1994 | WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001131A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | WO1994001128A1 Enhancement of thrombolytic therapy with deglycosylated plasminogen |
| 01/20/1994 | WO1994001127A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | WO1994001126A1 Compounds for inhibition of proteolysis |
| 01/20/1994 | WO1994001125A1 Composition and method of treating hepatitis b |
| 01/20/1994 | WO1994001124A1 METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b) |
| 01/20/1994 | WO1994001123A1 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder |
| 01/20/1994 | WO1994001120A1 Purification of factor ix |
| 01/20/1994 | WO1994001119A1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE α FOR TREATMENT OF TUMORS |
| 01/20/1994 | WO1994001118A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | WO1994001107A1 Benzimidazoles for alleviating stomach ulcers in swine |
| 01/20/1994 | WO1994001102A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | WO1994001093A1 Controlled porosity osmotic enalapril pump |
| 01/20/1994 | WO1994001086A1 Tissue irrigating solutions |
| 01/20/1994 | WO1994000990A1 Conserved victorin-binding vital protein |
| 01/20/1994 | WO1993021942A3 Use of mmp inhibitors |
| 01/20/1994 | DE4220566A1 Inhibitoren retroviraler Proteasen Inhibitors of retroviral proteases |
| 01/20/1994 | CA2140140A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2139945A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor xa |
| 01/20/1994 | CA2139837A1 A fungicidally active compound |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139641A1 Conserved victorin-binding vital protein |
| 01/20/1994 | CA2139573A1 Yeast promoter and its use |
| 01/20/1994 | CA2139572A1 Yeast promoter and its use |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2139437A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | CA2139431A1 Polypeptides having serotoninergie activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | CA2139429A1 Oligopeptide derivatives and their use in secondary cataract prevention |
| 01/20/1994 | CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | CA2139417A1 Benzothiazepine and benzoxazepine derivatives |
| 01/20/1994 | CA2139411A1 Ribozyme having a thermodynamically stable loop |
| 01/20/1994 | CA2139349A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | CA2139345A1 New biologically active polypeptides; preparation and use |
| 01/20/1994 | CA2139319A1 Self-stabilized oligonucleotides as therapeutic agents |
| 01/20/1994 | CA2138787A1 Alleviating stomach ulcers in swine |
| 01/20/1994 | CA2138644A1 Method of treating ophthalmic disorders using tgf-.beta. |
| 01/20/1994 | CA2137462A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | CA2135193A1 Novel flk-2 and analogs |
| 01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | CA2118586A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | CA2118585A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | CA2117099A1 Receptor derivatives having binding sites for human rhinoviruses |
| 01/19/1994 | EP0579363A1 Treatment of tropical spastic paresis with peptide T |
| 01/19/1994 | EP0579222A2 Lipid metabolism improving composition |
| 01/19/1994 | EP0578932A2 IL-2 receptor gamma chain molecule |
| 01/19/1994 | EP0578819A1 Icam-related protein |
| 01/19/1994 | EP0578790A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 01/19/1994 | EP0578784A1 Odorant receptors ans uses thereof |
| 01/19/1994 | EP0578774A1 Monoclonal antibodies to stem cell factor receptors |
| 01/19/1994 | EP0578745A1 Phosphorus containing compounds as inhibitors of retroviruses |
| 01/19/1994 | EP0578740A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets |
| 01/19/1994 | EP0578738A1 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 01/19/1994 | EP0578728A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa |
| 01/19/1994 | EP0578726A1 Virus inactivation method and pharmaceutical composition therefor. |
| 01/19/1994 | EP0504307B1 Method of treating septic shock |
| 01/19/1994 | EP0423262B1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it |
| 01/19/1994 | EP0420979B1 Lipid metabolism improving agent and method of its use |
| 01/19/1994 | EP0406416B1 Anti-hiv agent |
| 01/19/1994 | EP0382732B1 Superactive human insulin analogues |
| 01/19/1994 | EP0315687B1 (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin |
| 01/19/1994 | CN1080959A Recombinant stimulating factor of the neu receptor |
| 01/19/1994 | CN1080931A Calcium channel blocking polypeptides from filistata hibernalis |
| 01/19/1994 | CN1080930A Histamine derivatives and methods for their use as immunomodulators |
| 01/19/1994 | CN1080926A Cyclic peptide antifungal agents and process for preparation thereof |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/19/1994 | CN1080873A Application of inhibitor of plasmin aktivator in treatment of inflammation and trauma |
| 01/19/1994 | CN1080853A Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |